Deals, Mergers and Acquisitions, and Licensing - Pharmaceutical Executive

ADVERTISEMENT

  • Search
  • Suppliers
  • Careers

Enter a company or product name

KeywordLocation
About Search

Mergers, acquisitions, strategic partnerships, and product licensing. Plus, strategies and tactics for better deal-making

A Season in Financial Hell
April 1, 2009
From the depths of the Great Recession, Pharm Exec called in pros on all sides of the M&A business to help us deal.
Stream Power
February 1, 2009
Convert future revenue into present value with alternative approaches to access capital.
Place Your Bets
September 1, 2008
The industry is a-changing. Here are eight seminal events that describe how.
2007 in M&A: 44 deals, $79 billion
April 1, 2008
The year in pharma and biotech finance. Stock prices stabilized. Pharma M&A kept building. And the mid-cap biotechs finally got a little love.
Big Deals
February 1, 2008
Many say licensing is the new R&D. We've rounded up the unions to watch from the third quarter of 2007.
Pfizer and Glaxo Join Forces in HIV Venture
April 22, 2009
GSK Grabs Derma Firm for $2.9 Billion
April 22, 2009
Gilead Buys CV Therapeutics (Update 1)
March 12, 2009
Roche and Genentech Seal the Deal for $46.8 Billion
March 5, 2009
Merck Takes Unusual Merger Tactic in Schering Deal
March 4, 2009

ADVERTISEMENT
Click here